nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftriaxone—GLUL—obesity	0.503	0.907	CbGaD
Ceftriaxone—SLC22A11—Cimetidine—obesity	0.126	0.503	CbGbCtD
Ceftriaxone—SLC22A8—Cimetidine—obesity	0.0733	0.293	CbGbCtD
Ceftriaxone—ALB—obesity	0.0512	0.0924	CbGaD
Ceftriaxone—SLC22A6—Cimetidine—obesity	0.051	0.204	CbGbCtD
Ceftriaxone—GLUL—hindbrain—obesity	0.00205	0.103	CbGeAlD
Ceftriaxone—GLUL—gall bladder—obesity	0.00202	0.102	CbGeAlD
Ceftriaxone—GLUL—islet of Langerhans—obesity	0.00132	0.0668	CbGeAlD
Ceftriaxone—ALB—gall bladder—obesity	0.00125	0.063	CbGeAlD
Ceftriaxone—GLUL—respiratory system—obesity	0.00125	0.063	CbGeAlD
Ceftriaxone—GLUL—cardiovascular system—obesity	0.000957	0.0483	CbGeAlD
Ceftriaxone—GLUL—pituitary gland—obesity	0.000848	0.0427	CbGeAlD
Ceftriaxone—GLUL—adipose tissue—obesity	0.000844	0.0426	CbGeAlD
Ceftriaxone—SLC22A11—digestive system—obesity	0.000838	0.0422	CbGeAlD
Ceftriaxone—GLUL—digestive system—obesity	0.000795	0.0401	CbGeAlD
Ceftriaxone—GLUL—adrenal gland—obesity	0.000757	0.0382	CbGeAlD
Ceftriaxone—SLC22A11—endocrine gland—obesity	0.000692	0.0349	CbGeAlD
Ceftriaxone—Cefazolin—PON1—obesity	0.000689	0.468	CrCbGaD
Ceftriaxone—SLC15A1—digestive system—obesity	0.000657	0.0331	CbGeAlD
Ceftriaxone—GLUL—endocrine gland—obesity	0.000657	0.0331	CbGeAlD
Ceftriaxone—SLC15A2—respiratory system—obesity	0.000646	0.0326	CbGeAlD
Ceftriaxone—SLC22A11—liver—obesity	0.000624	0.0315	CbGeAlD
Ceftriaxone—GLUL—liver—obesity	0.000592	0.0299	CbGeAlD
Ceftriaxone—SLC15A1—endocrine gland—obesity	0.000543	0.0274	CbGeAlD
Ceftriaxone—SLC15A1—liver—obesity	0.000489	0.0247	CbGeAlD
Ceftriaxone—ALB—adrenal gland—obesity	0.000469	0.0236	CbGeAlD
Ceftriaxone—Hypertonia—Bupropion—obesity	0.000442	0.00393	CcSEcCtD
Ceftriaxone—Renal impairment—Sibutramine—obesity	0.000441	0.00392	CcSEcCtD
Ceftriaxone—Hyperkinesia—Bupropion—obesity	0.00044	0.00391	CcSEcCtD
Ceftriaxone—Palpitations—Diethylpropion—obesity	0.00044	0.00391	CcSEcCtD
Ceftriaxone—SLC15A2—pituitary gland—obesity	0.000438	0.0221	CbGeAlD
Ceftriaxone—Agitation—Cimetidine—obesity	0.000435	0.00386	CcSEcCtD
Ceftriaxone—Dermatitis atopic—Topiramate—obesity	0.000434	0.00386	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Sibutramine—obesity	0.000434	0.00385	CcSEcCtD
Ceftriaxone—Convulsion—Diethylpropion—obesity	0.000431	0.00383	CcSEcCtD
Ceftriaxone—Dizziness—Methamphetamine—obesity	0.000429	0.00382	CcSEcCtD
Ceftriaxone—Diarrhoea—Benzphetamine—obesity	0.000429	0.00381	CcSEcCtD
Ceftriaxone—Malaise—Cimetidine—obesity	0.000427	0.00379	CcSEcCtD
Ceftriaxone—Phlebitis—Bupropion—obesity	0.000425	0.00377	CcSEcCtD
Ceftriaxone—Leukopenia—Cimetidine—obesity	0.000424	0.00376	CcSEcCtD
Ceftriaxone—Hepatic function abnormal—Bupropion—obesity	0.000419	0.00372	CcSEcCtD
Ceftriaxone—Discomfort—Diethylpropion—obesity	0.000418	0.00372	CcSEcCtD
Ceftriaxone—Dizziness—Benzphetamine—obesity	0.000414	0.00368	CcSEcCtD
Ceftriaxone—Coagulopathy—Topiramate—obesity	0.000413	0.00367	CcSEcCtD
Ceftriaxone—Dyspepsia—Phentermine—obesity	0.000411	0.00365	CcSEcCtD
Ceftriaxone—Headache—Methamphetamine—obesity	0.000407	0.00361	CcSEcCtD
Ceftriaxone—Feeling abnormal—Phenylpropanolamine—obesity	0.000402	0.00357	CcSEcCtD
Ceftriaxone—Nephrolithiasis—Topiramate—obesity	0.0004	0.00355	CcSEcCtD
Ceftriaxone—Abdominal pain upper—Orlistat—obesity	0.000396	0.00352	CcSEcCtD
Ceftriaxone—Ataxia—Sibutramine—obesity	0.000395	0.00351	CcSEcCtD
Ceftriaxone—Blood creatinine increased—Sibutramine—obesity	0.000393	0.00349	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Diethylpropion—obesity	0.000392	0.00349	CcSEcCtD
Ceftriaxone—Headache—Benzphetamine—obesity	0.000392	0.00349	CcSEcCtD
Ceftriaxone—SLC15A2—adrenal gland—obesity	0.000391	0.0197	CbGeAlD
Ceftriaxone—Diarrhoea—Phendimetrazine—obesity	0.000391	0.00347	CcSEcCtD
Ceftriaxone—Dermatitis exfoliative—Bupropion—obesity	0.000388	0.00345	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Cimetidine—obesity	0.000386	0.00343	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Cimetidine—obesity	0.000378	0.00336	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Sibutramine—obesity	0.000378	0.00336	CcSEcCtD
Ceftriaxone—Dizziness—Phendimetrazine—obesity	0.000377	0.00335	CcSEcCtD
Ceftriaxone—Nausea—Benzphetamine—obesity	0.000372	0.0033	CcSEcCtD
Ceftriaxone—Urticaria—Phentermine—obesity	0.000371	0.00329	CcSEcCtD
Ceftriaxone—Abdominal pain—Phentermine—obesity	0.000369	0.00328	CcSEcCtD
Ceftriaxone—Bronchospasm—Orlistat—obesity	0.000369	0.00328	CcSEcCtD
Ceftriaxone—Pancreatitis—Orlistat—obesity	0.000368	0.00327	CcSEcCtD
Ceftriaxone—ALB—liver—obesity	0.000367	0.0185	CbGeAlD
Ceftriaxone—Sweating increased—Orlistat—obesity	0.000365	0.00325	CcSEcCtD
Ceftriaxone—Eosinophilia—Sibutramine—obesity	0.000359	0.00319	CcSEcCtD
Ceftriaxone—Hypersensitivity—Phenylpropanolamine—obesity	0.000359	0.00319	CcSEcCtD
Ceftriaxone—Headache—Phendimetrazine—obesity	0.000358	0.00318	CcSEcCtD
Ceftriaxone—Dyspepsia—Diethylpropion—obesity	0.000357	0.00317	CcSEcCtD
Ceftriaxone—Oliguria—Topiramate—obesity	0.000349	0.0031	CcSEcCtD
Ceftriaxone—Glossitis—Topiramate—obesity	0.000349	0.0031	CcSEcCtD
Ceftriaxone—Drug interaction—Topiramate—obesity	0.000346	0.00308	CcSEcCtD
Ceftriaxone—Ataxia—Bupropion—obesity	0.000344	0.00306	CcSEcCtD
Ceftriaxone—SLC15A2—endocrine gland—obesity	0.000339	0.0171	CbGeAlD
Ceftriaxone—Nausea—Phendimetrazine—obesity	0.000339	0.00301	CcSEcCtD
Ceftriaxone—Feeling abnormal—Diethylpropion—obesity	0.000335	0.00297	CcSEcCtD
Ceftriaxone—Abdominal pain upper—Bupropion—obesity	0.000334	0.00297	CcSEcCtD
Ceftriaxone—Renal failure—Orlistat—obesity	0.000329	0.00292	CcSEcCtD
Ceftriaxone—Urticaria—Diethylpropion—obesity	0.000322	0.00286	CcSEcCtD
Ceftriaxone—Dizziness—Phenylpropanolamine—obesity	0.000322	0.00286	CcSEcCtD
Ceftriaxone—Vaginal inflammation—Topiramate—obesity	0.000321	0.00285	CcSEcCtD
Ceftriaxone—Diarrhoea—Phentermine—obesity	0.000319	0.00284	CcSEcCtD
Ceftriaxone—Feeling abnormal—Cimetidine—obesity	0.000318	0.00283	CcSEcCtD
Ceftriaxone—Renal failure—Sibutramine—obesity	0.000318	0.00283	CcSEcCtD
Ceftriaxone—Stomatitis—Sibutramine—obesity	0.000315	0.0028	CcSEcCtD
Ceftriaxone—Bronchospasm—Bupropion—obesity	0.000311	0.00276	CcSEcCtD
Ceftriaxone—Pancreatitis—Bupropion—obesity	0.00031	0.00276	CcSEcCtD
Ceftriaxone—Vomiting—Phenylpropanolamine—obesity	0.00031	0.00275	CcSEcCtD
Ceftriaxone—Dizziness—Phentermine—obesity	0.000309	0.00274	CcSEcCtD
Ceftriaxone—Haematuria—Sibutramine—obesity	0.000309	0.00274	CcSEcCtD
Ceftriaxone—Sweating increased—Bupropion—obesity	0.000308	0.00274	CcSEcCtD
Ceftriaxone—Rash—Phenylpropanolamine—obesity	0.000307	0.00273	CcSEcCtD
Ceftriaxone—Dermatitis—Phenylpropanolamine—obesity	0.000307	0.00273	CcSEcCtD
Ceftriaxone—Candida infection—Topiramate—obesity	0.000307	0.00273	CcSEcCtD
Ceftriaxone—Body temperature increased—Cimetidine—obesity	0.000305	0.00271	CcSEcCtD
Ceftriaxone—Epistaxis—Sibutramine—obesity	0.000305	0.00271	CcSEcCtD
Ceftriaxone—Vaginal infection—Topiramate—obesity	0.000303	0.00269	CcSEcCtD
Ceftriaxone—Haemoglobin—Orlistat—obesity	0.000302	0.00268	CcSEcCtD
Ceftriaxone—Haemorrhage—Orlistat—obesity	0.0003	0.00267	CcSEcCtD
Ceftriaxone—Vomiting—Phentermine—obesity	0.000297	0.00264	CcSEcCtD
Ceftriaxone—Rash—Phentermine—obesity	0.000294	0.00261	CcSEcCtD
Ceftriaxone—Dermatitis—Phentermine—obesity	0.000294	0.00261	CcSEcCtD
Ceftriaxone—Headache—Phentermine—obesity	0.000292	0.0026	CcSEcCtD
Ceftriaxone—Haemoglobin—Sibutramine—obesity	0.000292	0.00259	CcSEcCtD
Ceftriaxone—Haemorrhage—Sibutramine—obesity	0.00029	0.00258	CcSEcCtD
Ceftriaxone—Nausea—Phenylpropanolamine—obesity	0.00029	0.00257	CcSEcCtD
Ceftriaxone—Hypersensitivity—Cimetidine—obesity	0.000285	0.00253	CcSEcCtD
Ceftriaxone—Hypertonia—Topiramate—obesity	0.000282	0.0025	CcSEcCtD
Ceftriaxone—Hyperkinesia—Topiramate—obesity	0.00028	0.00249	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Bupropion—obesity	0.00028	0.00248	CcSEcCtD
Ceftriaxone—Diarrhoea—Diethylpropion—obesity	0.000278	0.00247	CcSEcCtD
Ceftriaxone—Nausea—Phentermine—obesity	0.000277	0.00246	CcSEcCtD
Ceftriaxone—Stomatitis—Bupropion—obesity	0.000275	0.00244	CcSEcCtD
Ceftriaxone—Jaundice—Bupropion—obesity	0.000275	0.00244	CcSEcCtD
Ceftriaxone—Phlebitis—Topiramate—obesity	0.000271	0.0024	CcSEcCtD
Ceftriaxone—Dizziness—Diethylpropion—obesity	0.000268	0.00238	CcSEcCtD
Ceftriaxone—Epistaxis—Bupropion—obesity	0.000266	0.00236	CcSEcCtD
Ceftriaxone—Diarrhoea—Cimetidine—obesity	0.000264	0.00235	CcSEcCtD
Ceftriaxone—Chills—Sibutramine—obesity	0.000261	0.00232	CcSEcCtD
Ceftriaxone—Vomiting—Diethylpropion—obesity	0.000258	0.00229	CcSEcCtD
Ceftriaxone—Flatulence—Orlistat—obesity	0.000257	0.00229	CcSEcCtD
Ceftriaxone—Rash—Diethylpropion—obesity	0.000256	0.00227	CcSEcCtD
Ceftriaxone—Dysgeusia—Orlistat—obesity	0.000256	0.00227	CcSEcCtD
Ceftriaxone—Dermatitis—Diethylpropion—obesity	0.000256	0.00227	CcSEcCtD
Ceftriaxone—Dizziness—Cimetidine—obesity	0.000255	0.00227	CcSEcCtD
Ceftriaxone—Haemoglobin—Bupropion—obesity	0.000255	0.00226	CcSEcCtD
Ceftriaxone—Headache—Diethylpropion—obesity	0.000254	0.00226	CcSEcCtD
Ceftriaxone—Haemorrhage—Bupropion—obesity	0.000253	0.00225	CcSEcCtD
Ceftriaxone—Flatulence—Sibutramine—obesity	0.000249	0.00221	CcSEcCtD
Ceftriaxone—Dysgeusia—Sibutramine—obesity	0.000248	0.0022	CcSEcCtD
Ceftriaxone—Vomiting—Cimetidine—obesity	0.000246	0.00218	CcSEcCtD
Ceftriaxone—Rash—Cimetidine—obesity	0.000244	0.00216	CcSEcCtD
Ceftriaxone—Dermatitis—Cimetidine—obesity	0.000243	0.00216	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Orlistat—obesity	0.000242	0.00215	CcSEcCtD
Ceftriaxone—Headache—Cimetidine—obesity	0.000242	0.00215	CcSEcCtD
Ceftriaxone—Nausea—Diethylpropion—obesity	0.000241	0.00214	CcSEcCtD
Ceftriaxone—Erythema multiforme—Bupropion—obesity	0.000239	0.00213	CcSEcCtD
Ceftriaxone—Malaise—Orlistat—obesity	0.000236	0.00209	CcSEcCtD
Ceftriaxone—Flushing—Bupropion—obesity	0.000235	0.00209	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Sibutramine—obesity	0.000235	0.00208	CcSEcCtD
Ceftriaxone—Anaemia—Sibutramine—obesity	0.000234	0.00208	CcSEcCtD
Ceftriaxone—Agitation—Sibutramine—obesity	0.000232	0.00206	CcSEcCtD
Ceftriaxone—Palpitations—Orlistat—obesity	0.000231	0.00205	CcSEcCtD
Ceftriaxone—Nausea—Cimetidine—obesity	0.000229	0.00204	CcSEcCtD
Ceftriaxone—Malaise—Sibutramine—obesity	0.000228	0.00203	CcSEcCtD
Ceftriaxone—Chills—Bupropion—obesity	0.000227	0.00202	CcSEcCtD
Ceftriaxone—Convulsion—Orlistat—obesity	0.000226	0.00201	CcSEcCtD
Ceftriaxone—Leukopenia—Sibutramine—obesity	0.000226	0.00201	CcSEcCtD
Ceftriaxone—Palpitations—Sibutramine—obesity	0.000223	0.00199	CcSEcCtD
Ceftriaxone—Discomfort—Orlistat—obesity	0.00022	0.00195	CcSEcCtD
Ceftriaxone—Ataxia—Topiramate—obesity	0.000219	0.00195	CcSEcCtD
Ceftriaxone—Convulsion—Sibutramine—obesity	0.000219	0.00195	CcSEcCtD
Ceftriaxone—Blood creatinine increased—Topiramate—obesity	0.000218	0.00194	CcSEcCtD
Ceftriaxone—Flatulence—Bupropion—obesity	0.000217	0.00193	CcSEcCtD
Ceftriaxone—Dysgeusia—Bupropion—obesity	0.000216	0.00192	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Orlistat—obesity	0.000213	0.00189	CcSEcCtD
Ceftriaxone—Oedema—Orlistat—obesity	0.000213	0.00189	CcSEcCtD
Ceftriaxone—Abdominal pain upper—Topiramate—obesity	0.000213	0.00189	CcSEcCtD
Ceftriaxone—Discomfort—Sibutramine—obesity	0.000213	0.00189	CcSEcCtD
Ceftriaxone—Infection—Orlistat—obesity	0.000212	0.00188	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Topiramate—obesity	0.00021	0.00187	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Topiramate—obesity	0.00021	0.00187	CcSEcCtD
Ceftriaxone—Cefotetan—ALB—obesity	0.000209	0.142	CrCbGaD
Ceftriaxone—Anaphylactic shock—Sibutramine—obesity	0.000206	0.00183	CcSEcCtD
Ceftriaxone—Oedema—Sibutramine—obesity	0.000206	0.00183	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Orlistat—obesity	0.000206	0.00183	CcSEcCtD
Ceftriaxone—Infection—Sibutramine—obesity	0.000205	0.00182	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Bupropion—obesity	0.000205	0.00182	CcSEcCtD
Ceftriaxone—Anaemia—Bupropion—obesity	0.000204	0.00181	CcSEcCtD
Ceftriaxone—Agitation—Bupropion—obesity	0.000203	0.0018	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Sibutramine—obesity	0.000202	0.0018	CcSEcCtD
Ceftriaxone—Eosinophilia—Topiramate—obesity	0.0002	0.00177	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Sibutramine—obesity	0.0002	0.00177	CcSEcCtD
Ceftriaxone—Malaise—Bupropion—obesity	0.000199	0.00177	CcSEcCtD
Ceftriaxone—Pancreatitis—Topiramate—obesity	0.000198	0.00176	CcSEcCtD
Ceftriaxone—Leukopenia—Bupropion—obesity	0.000197	0.00175	CcSEcCtD
Ceftriaxone—Sweating increased—Topiramate—obesity	0.000196	0.00174	CcSEcCtD
Ceftriaxone—Palpitations—Bupropion—obesity	0.000195	0.00173	CcSEcCtD
Ceftriaxone—Paraesthesia—Orlistat—obesity	0.000191	0.0017	CcSEcCtD
Ceftriaxone—Convulsion—Bupropion—obesity	0.000191	0.0017	CcSEcCtD
Ceftriaxone—Neutropenia—Topiramate—obesity	0.000188	0.00167	CcSEcCtD
Ceftriaxone—Dyspepsia—Orlistat—obesity	0.000188	0.00167	CcSEcCtD
Ceftriaxone—Discomfort—Bupropion—obesity	0.000185	0.00165	CcSEcCtD
Ceftriaxone—Paraesthesia—Sibutramine—obesity	0.000185	0.00165	CcSEcCtD
Ceftriaxone—Pain—Orlistat—obesity	0.000182	0.00162	CcSEcCtD
Ceftriaxone—Cefpiramide—ALB—obesity	0.000182	0.123	CrCbGaD
Ceftriaxone—Dyspepsia—Sibutramine—obesity	0.000182	0.00161	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Bupropion—obesity	0.00018	0.0016	CcSEcCtD
Ceftriaxone—Oedema—Bupropion—obesity	0.00018	0.0016	CcSEcCtD
Ceftriaxone—Infection—Bupropion—obesity	0.000179	0.00159	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Topiramate—obesity	0.000178	0.00158	CcSEcCtD
Ceftriaxone—Renal failure—Topiramate—obesity	0.000177	0.00157	CcSEcCtD
Ceftriaxone—Pain—Sibutramine—obesity	0.000176	0.00157	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Bupropion—obesity	0.000176	0.00156	CcSEcCtD
Ceftriaxone—Feeling abnormal—Orlistat—obesity	0.000176	0.00156	CcSEcCtD
Ceftriaxone—Stomatitis—Topiramate—obesity	0.000175	0.00156	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Orlistat—obesity	0.000174	0.00155	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Bupropion—obesity	0.000174	0.00155	CcSEcCtD
Ceftriaxone—Haematuria—Topiramate—obesity	0.000171	0.00152	CcSEcCtD
Ceftriaxone—Feeling abnormal—Sibutramine—obesity	0.00017	0.00151	CcSEcCtD
Ceftriaxone—Epistaxis—Topiramate—obesity	0.00017	0.00151	CcSEcCtD
Ceftriaxone—Urticaria—Orlistat—obesity	0.000169	0.0015	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Sibutramine—obesity	0.000169	0.0015	CcSEcCtD
Ceftriaxone—Abdominal pain—Orlistat—obesity	0.000169	0.0015	CcSEcCtD
Ceftriaxone—Body temperature increased—Orlistat—obesity	0.000169	0.0015	CcSEcCtD
Ceftriaxone—Agranulocytosis—Topiramate—obesity	0.000168	0.00149	CcSEcCtD
Ceftriaxone—Urticaria—Sibutramine—obesity	0.000164	0.00146	CcSEcCtD
Ceftriaxone—Abdominal pain—Sibutramine—obesity	0.000163	0.00145	CcSEcCtD
Ceftriaxone—Body temperature increased—Sibutramine—obesity	0.000163	0.00145	CcSEcCtD
Ceftriaxone—Haemoglobin—Topiramate—obesity	0.000162	0.00144	CcSEcCtD
Ceftriaxone—Paraesthesia—Bupropion—obesity	0.000162	0.00144	CcSEcCtD
Ceftriaxone—Haemorrhage—Topiramate—obesity	0.000161	0.00143	CcSEcCtD
Ceftriaxone—Cefonicid—ALB—obesity	0.000158	0.108	CrCbGaD
Ceftriaxone—Dyspepsia—Bupropion—obesity	0.000158	0.00141	CcSEcCtD
Ceftriaxone—Hypersensitivity—Orlistat—obesity	0.000157	0.0014	CcSEcCtD
Ceftriaxone—Pain—Bupropion—obesity	0.000154	0.00137	CcSEcCtD
Ceftriaxone—Erythema multiforme—Topiramate—obesity	0.000153	0.00136	CcSEcCtD
Ceftriaxone—Hypersensitivity—Sibutramine—obesity	0.000152	0.00135	CcSEcCtD
Ceftriaxone—Pruritus—Orlistat—obesity	0.000151	0.00134	CcSEcCtD
Ceftriaxone—Flushing—Topiramate—obesity	0.00015	0.00133	CcSEcCtD
Ceftriaxone—Feeling abnormal—Bupropion—obesity	0.000148	0.00132	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Bupropion—obesity	0.000147	0.00131	CcSEcCtD
Ceftriaxone—Pruritus—Sibutramine—obesity	0.000146	0.0013	CcSEcCtD
Ceftriaxone—Diarrhoea—Orlistat—obesity	0.000146	0.0013	CcSEcCtD
Ceftriaxone—Chills—Topiramate—obesity	0.000145	0.00129	CcSEcCtD
Ceftriaxone—Urticaria—Bupropion—obesity	0.000143	0.00127	CcSEcCtD
Ceftriaxone—Abdominal pain—Bupropion—obesity	0.000142	0.00126	CcSEcCtD
Ceftriaxone—Body temperature increased—Bupropion—obesity	0.000142	0.00126	CcSEcCtD
Ceftriaxone—Diarrhoea—Sibutramine—obesity	0.000141	0.00125	CcSEcCtD
Ceftriaxone—Dizziness—Orlistat—obesity	0.000141	0.00125	CcSEcCtD
Ceftriaxone—Flatulence—Topiramate—obesity	0.000138	0.00123	CcSEcCtD
Ceftriaxone—Dysgeusia—Topiramate—obesity	0.000138	0.00122	CcSEcCtD
Ceftriaxone—Dizziness—Sibutramine—obesity	0.000136	0.00121	CcSEcCtD
Ceftriaxone—Vomiting—Orlistat—obesity	0.000136	0.0012	CcSEcCtD
Ceftriaxone—Rash—Orlistat—obesity	0.000134	0.00119	CcSEcCtD
Ceftriaxone—Dermatitis—Orlistat—obesity	0.000134	0.00119	CcSEcCtD
Ceftriaxone—Headache—Orlistat—obesity	0.000134	0.00119	CcSEcCtD
Ceftriaxone—Hypersensitivity—Bupropion—obesity	0.000133	0.00118	CcSEcCtD
Ceftriaxone—Vomiting—Sibutramine—obesity	0.000131	0.00117	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Topiramate—obesity	0.00013	0.00116	CcSEcCtD
Ceftriaxone—Rash—Sibutramine—obesity	0.00013	0.00116	CcSEcCtD
Ceftriaxone—Dermatitis—Sibutramine—obesity	0.00013	0.00115	CcSEcCtD
Ceftriaxone—Anaemia—Topiramate—obesity	0.00013	0.00115	CcSEcCtD
Ceftriaxone—Headache—Sibutramine—obesity	0.000129	0.00115	CcSEcCtD
Ceftriaxone—Agitation—Topiramate—obesity	0.000129	0.00115	CcSEcCtD
Ceftriaxone—Pruritus—Bupropion—obesity	0.000127	0.00113	CcSEcCtD
Ceftriaxone—Nausea—Orlistat—obesity	0.000127	0.00113	CcSEcCtD
Ceftriaxone—Malaise—Topiramate—obesity	0.000127	0.00113	CcSEcCtD
Ceftriaxone—Leukopenia—Topiramate—obesity	0.000126	0.00112	CcSEcCtD
Ceftriaxone—Palpitations—Topiramate—obesity	0.000124	0.0011	CcSEcCtD
Ceftriaxone—Diarrhoea—Bupropion—obesity	0.000123	0.00109	CcSEcCtD
Ceftriaxone—Nausea—Sibutramine—obesity	0.000123	0.00109	CcSEcCtD
Ceftriaxone—Convulsion—Topiramate—obesity	0.000122	0.00108	CcSEcCtD
Ceftriaxone—Dizziness—Bupropion—obesity	0.000119	0.00106	CcSEcCtD
Ceftriaxone—Discomfort—Topiramate—obesity	0.000118	0.00105	CcSEcCtD
Ceftriaxone—Oedema—Topiramate—obesity	0.000115	0.00102	CcSEcCtD
Ceftriaxone—Vomiting—Bupropion—obesity	0.000114	0.00102	CcSEcCtD
Ceftriaxone—Infection—Topiramate—obesity	0.000114	0.00101	CcSEcCtD
Ceftriaxone—Rash—Bupropion—obesity	0.000113	0.00101	CcSEcCtD
Ceftriaxone—Dermatitis—Bupropion—obesity	0.000113	0.00101	CcSEcCtD
Ceftriaxone—Headache—Bupropion—obesity	0.000113	0.001	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Topiramate—obesity	0.000112	0.000997	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Topiramate—obesity	0.000111	0.000984	CcSEcCtD
Ceftriaxone—Nausea—Bupropion—obesity	0.000107	0.000949	CcSEcCtD
Ceftriaxone—Paraesthesia—Topiramate—obesity	0.000103	0.000914	CcSEcCtD
Ceftriaxone—Dyspepsia—Topiramate—obesity	0.000101	0.000896	CcSEcCtD
Ceftriaxone—Pain—Topiramate—obesity	9.8e-05	0.000871	CcSEcCtD
Ceftriaxone—Feeling abnormal—Topiramate—obesity	9.45e-05	0.000839	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Topiramate—obesity	9.37e-05	0.000833	CcSEcCtD
Ceftriaxone—Cefoperazone—ALB—obesity	9.33e-05	0.0634	CrCbGaD
Ceftriaxone—Urticaria—Topiramate—obesity	9.11e-05	0.000809	CcSEcCtD
Ceftriaxone—Abdominal pain—Topiramate—obesity	9.06e-05	0.000805	CcSEcCtD
Ceftriaxone—Body temperature increased—Topiramate—obesity	9.06e-05	0.000805	CcSEcCtD
Ceftriaxone—Hypersensitivity—Topiramate—obesity	8.45e-05	0.00075	CcSEcCtD
Ceftriaxone—Pruritus—Topiramate—obesity	8.11e-05	0.00072	CcSEcCtD
Ceftriaxone—Diarrhoea—Topiramate—obesity	7.84e-05	0.000697	CcSEcCtD
Ceftriaxone—Cefazolin—ALB—obesity	7.67e-05	0.0521	CrCbGaD
Ceftriaxone—Dizziness—Topiramate—obesity	7.58e-05	0.000673	CcSEcCtD
Ceftriaxone—Vomiting—Topiramate—obesity	7.29e-05	0.000647	CcSEcCtD
Ceftriaxone—Rash—Topiramate—obesity	7.23e-05	0.000642	CcSEcCtD
Ceftriaxone—Dermatitis—Topiramate—obesity	7.22e-05	0.000641	CcSEcCtD
Ceftriaxone—Headache—Topiramate—obesity	7.18e-05	0.000638	CcSEcCtD
Ceftriaxone—Nausea—Topiramate—obesity	6.81e-05	0.000605	CcSEcCtD
Ceftriaxone—Cefalotin—ALB—obesity	6.37e-05	0.0433	CrCbGaD
Ceftriaxone—ALB—Metabolism—PPM1L—obesity	2.2e-05	0.000357	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—APOA1—obesity	2.19e-05	0.000355	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—PPARA—obesity	2.16e-05	0.000351	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—TNF—obesity	2.16e-05	0.000351	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—PLG—obesity	2.15e-05	0.00035	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—IL6—obesity	2.14e-05	0.000348	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—SREBF2—obesity	2.12e-05	0.000345	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—TRPV1—obesity	2.1e-05	0.00034	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PRKG1—obesity	2.06e-05	0.000334	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—LPA—obesity	2.05e-05	0.000333	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PIK3CG—obesity	2.03e-05	0.00033	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—APOA1—obesity	2.03e-05	0.000329	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—HK1—obesity	2.02e-05	0.000328	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—CD36—obesity	2.01e-05	0.000327	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—INPP5E—obesity	2.01e-05	0.000327	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GPT—obesity	2.01e-05	0.000327	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—UQCRC2—obesity	2.01e-05	0.000327	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—LPIN1—obesity	2.01e-05	0.000326	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—GNB3—obesity	2e-05	0.000324	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—HMOX1—obesity	1.99e-05	0.000323	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—TGFB1—obesity	1.98e-05	0.000322	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—APOA5—obesity	1.97e-05	0.000319	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PPARG—obesity	1.96e-05	0.000318	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PRKCD—obesity	1.95e-05	0.000317	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—GNAS—obesity	1.95e-05	0.000316	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—POMC—obesity	1.94e-05	0.000314	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—PPARA—obesity	1.93e-05	0.000312	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—INS—obesity	1.92e-05	0.000312	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—APOB—obesity	1.9e-05	0.000309	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PRKAR2B—obesity	1.9e-05	0.000309	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—obesity	1.89e-05	0.000307	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—ALB—obesity	1.88e-05	0.000304	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CLOCK—obesity	1.88e-05	0.000304	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ME1—obesity	1.87e-05	0.000304	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ALDH6A1—obesity	1.87e-05	0.000304	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SUCLG2—obesity	1.87e-05	0.000304	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—SULT2A1—obesity	1.83e-05	0.000297	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—APOA1—obesity	1.81e-05	0.000293	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PIK3CD—obesity	1.79e-05	0.00029	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC22A1—obesity	1.78e-05	0.000289	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ALB—obesity	1.76e-05	0.000286	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—UCP1—obesity	1.76e-05	0.000285	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PNPLA3—obesity	1.76e-05	0.000285	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—COX7C—obesity	1.76e-05	0.000285	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—APOA1—obesity	1.76e-05	0.000285	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—IL6—obesity	1.74e-05	0.000283	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—ALB—obesity	1.73e-05	0.000281	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—TNF—obesity	1.72e-05	0.000279	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—TF—obesity	1.71e-05	0.000277	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PIK3R1—obesity	1.69e-05	0.000274	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—NOS3—obesity	1.69e-05	0.000274	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PRKCB—obesity	1.67e-05	0.000272	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—F2—obesity	1.67e-05	0.000272	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CPT1A—obesity	1.67e-05	0.000271	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—DGAT2—obesity	1.67e-05	0.000271	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CS—obesity	1.67e-05	0.000271	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SUCLA2—obesity	1.67e-05	0.000271	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CPS1—obesity	1.67e-05	0.000271	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—PRKAR2B—obesity	1.65e-05	0.000267	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—LIPC—obesity	1.63e-05	0.000264	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—APOC3—obesity	1.62e-05	0.000263	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—ALB—obesity	1.61e-05	0.000261	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—PPARA—obesity	1.61e-05	0.000261	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PIK3CG—obesity	1.6e-05	0.00026	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—LIPE—obesity	1.59e-05	0.000258	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—MUT—obesity	1.59e-05	0.000258	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CETP—obesity	1.57e-05	0.000255	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PIK3CB—obesity	1.56e-05	0.000253	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—SDC1—obesity	1.55e-05	0.000252	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—GCK—obesity	1.55e-05	0.000251	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PTGS2—obesity	1.54e-05	0.000251	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—AKR1C3—obesity	1.53e-05	0.000248	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—DGAT1—obesity	1.52e-05	0.000247	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYB5A—obesity	1.52e-05	0.000247	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—APOA1—obesity	1.51e-05	0.000245	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—SCARB1—obesity	1.51e-05	0.000244	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—CETP—obesity	1.49e-05	0.000243	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—TF—obesity	1.48e-05	0.00024	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ACLY—obesity	1.47e-05	0.000238	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—IGF1—obesity	1.47e-05	0.000238	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—AKT2—obesity	1.47e-05	0.000238	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—SREBF1—obesity	1.46e-05	0.000237	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—NOS1—obesity	1.43e-05	0.000232	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—ALB—obesity	1.43e-05	0.000232	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ENPP1—obesity	1.42e-05	0.00023	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ALOX12—obesity	1.42e-05	0.00023	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—TFRC—obesity	1.42e-05	0.00023	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PIK3CD—obesity	1.41e-05	0.000229	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—SERPINE1—obesity	1.39e-05	0.000226	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PTPN1—obesity	1.39e-05	0.000226	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—FASN—obesity	1.39e-05	0.000226	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—BCHE—obesity	1.39e-05	0.000225	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—IL6—obesity	1.39e-05	0.000225	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HMGCS1—obesity	1.37e-05	0.000223	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—RHOA—obesity	1.34e-05	0.000218	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ACADM—obesity	1.33e-05	0.000216	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PNPLA2—obesity	1.33e-05	0.000216	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PLIN1—obesity	1.33e-05	0.000216	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SAT1—obesity	1.33e-05	0.000216	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PFKFB3—obesity	1.33e-05	0.000216	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ANGPTL4—obesity	1.33e-05	0.000216	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PIK3R1—obesity	1.33e-05	0.000216	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—OXCT1—obesity	1.3e-05	0.00021	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYTB—obesity	1.3e-05	0.00021	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ACACB—obesity	1.3e-05	0.00021	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PLG—obesity	1.29e-05	0.00021	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PNLIP—obesity	1.26e-05	0.000205	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SRD5A1—obesity	1.26e-05	0.000205	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SDC3—obesity	1.23e-05	0.0002	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PIK3CB—obesity	1.23e-05	0.000199	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—GGT1—obesity	1.23e-05	0.000199	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—NCOA1—obesity	1.21e-05	0.000196	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—STS—obesity	1.21e-05	0.000196	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP26B1—obesity	1.21e-05	0.000196	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HK2—obesity	1.21e-05	0.000196	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC2A4—obesity	1.2e-05	0.000196	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—GNB3—obesity	1.2e-05	0.000195	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—ALB—obesity	1.19e-05	0.000194	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CYP19A1—obesity	1.19e-05	0.000193	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—CYCS—obesity	1.19e-05	0.000193	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PPARD—obesity	1.18e-05	0.000191	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—IGF2—obesity	1.18e-05	0.000191	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—GNAS—obesity	1.17e-05	0.00019	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SLC27A1—obesity	1.16e-05	0.000188	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—NCOA1—obesity	1.15e-05	0.000187	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—APOB—obesity	1.14e-05	0.000186	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—FABP4—obesity	1.13e-05	0.000184	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GLUL—obesity	1.13e-05	0.000184	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—PLG—obesity	1.12e-05	0.000182	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—obesity	1.09e-05	0.000177	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HSD11B1—obesity	1.07e-05	0.000174	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—UCP2—obesity	1.07e-05	0.000174	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—UCP3—obesity	1.07e-05	0.000174	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ECHS1—obesity	1.07e-05	0.000174	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ADH1B—obesity	1.06e-05	0.000172	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—APOB—obesity	1.04e-05	0.000169	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GPAM—obesity	1.04e-05	0.000169	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PPARGC1B—obesity	1.04e-05	0.000169	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ACSL1—obesity	1.04e-05	0.000169	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—GNB3—obesity	1.04e-05	0.000169	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—CD36—obesity	1.04e-05	0.000168	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—HMOX1—obesity	1.03e-05	0.000168	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—GNAS—obesity	1.01e-05	0.000164	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HADH—obesity	1.01e-05	0.000164	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PCK1—obesity	1.01e-05	0.000164	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—FADS1—obesity	1.01e-05	0.000164	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PRKCD—obesity	1.01e-05	0.000163	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—LPL—obesity	9.94e-06	0.000161	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—APOB—obesity	9.9e-06	0.000161	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ACP5—obesity	9.83e-06	0.000159	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—GPX1—obesity	9.7e-06	0.000157	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—G6PD—obesity	9.58e-06	0.000155	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PIK3CA—obesity	9.5e-06	0.000154	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HK1—obesity	9.46e-06	0.000153	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SREBF2—obesity	9.46e-06	0.000153	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CD36—obesity	9.45e-06	0.000153	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—LPA—obesity	9.13e-06	0.000148	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—CAV1—obesity	9.07e-06	0.000147	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—APOA1—obesity	9.05e-06	0.000147	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—LPIN1—obesity	8.94e-06	0.000145	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—TGFB1—obesity	8.8e-06	0.000143	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PPARA—obesity	8.78e-06	0.000143	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—APOA5—obesity	8.76e-06	0.000142	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—F2—obesity	8.63e-06	0.00014	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PRKCB—obesity	8.63e-06	0.00014	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—AGT—obesity	8.51e-06	0.000138	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SLC22A1—obesity	8.35e-06	0.000136	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CLOCK—obesity	8.35e-06	0.000136	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—PPARA—obesity	8.35e-06	0.000136	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—APOE—obesity	8.33e-06	0.000135	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PIK3CG—obesity	8.26e-06	0.000134	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CAV1—obesity	8.26e-06	0.000134	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—APOA1—obesity	8.24e-06	0.000134	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SULT2A1—obesity	8.14e-06	0.000132	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GLP1R—obesity	8.14e-06	0.000132	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—DPYD—obesity	8.01e-06	0.00013	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—APOA1—obesity	7.83e-06	0.000127	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—AKT1—obesity	7.76e-06	0.000126	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PRKAR2B—obesity	7.71e-06	0.000125	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—DCN—obesity	7.65e-06	0.000124	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—IGF1—obesity	7.57e-06	0.000123	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—AKT2—obesity	7.56e-06	0.000123	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PIK3CG—obesity	7.52e-06	0.000122	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PIK3CA—obesity	7.49e-06	0.000122	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CPT1A—obesity	7.45e-06	0.000121	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NAMPT—obesity	7.3e-06	0.000119	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PIK3CD—obesity	7.26e-06	0.000118	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PPARG—obesity	7.26e-06	0.000118	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—LIPC—obesity	7.26e-06	0.000118	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GCK—obesity	7.26e-06	0.000118	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—APOC3—obesity	7.21e-06	0.000117	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SERPINE1—obesity	7.18e-06	0.000117	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—POMC—obesity	7.16e-06	0.000116	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CETP—obesity	7e-06	0.000114	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—RHOA—obesity	6.93e-06	0.000112	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SDC1—obesity	6.92e-06	0.000112	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PIK3R1—obesity	6.86e-06	0.000111	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—NOS3—obesity	6.86e-06	0.000111	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—AKR1C3—obesity	6.81e-06	0.000111	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SCARB1—obesity	6.7e-06	0.000109	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PIK3CD—obesity	6.61e-06	0.000107	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SREBF1—obesity	6.51e-06	0.000106	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GOT2—obesity	6.33e-06	0.000103	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PIK3CB—obesity	6.33e-06	0.000103	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PIK3R1—obesity	6.24e-06	0.000101	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—FASN—obesity	6.2e-06	0.000101	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—BCHE—obesity	6.17e-06	0.0001	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—AKT1—obesity	6.12e-06	9.93e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP2E1—obesity	5.95e-06	9.66e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NQO1—obesity	5.89e-06	9.55e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—obesity	5.76e-06	9.35e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PTGS2—obesity	5.71e-06	9.27e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SLC2A4—obesity	5.64e-06	9.16e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GCG—obesity	5.64e-06	9.16e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYCS—obesity	5.57e-06	9.04e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GGT1—obesity	5.47e-06	8.87e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GOT1—obesity	5.47e-06	8.87e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NCOA1—obesity	5.38e-06	8.74e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP19A1—obesity	5.31e-06	8.61e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—STK11—obesity	5.31e-06	8.61e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—COMT—obesity	4.93e-06	8e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PPARGC1A—obesity	4.86e-06	7.89e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GNB3—obesity	4.86e-06	7.89e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HMOX1—obesity	4.84e-06	7.86e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GNAS—obesity	4.74e-06	7.69e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—APOB—obesity	4.64e-06	7.53e-05	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—TGFB1—obesity	4.54e-06	7.36e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—LPL—obesity	4.43e-06	7.19e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GPX1—obesity	4.32e-06	7.01e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CD36—obesity	4.21e-06	6.83e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—MTHFR—obesity	3.99e-06	6.47e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PPARA—obesity	3.91e-06	6.35e-05	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PIK3CA—obesity	3.86e-06	6.26e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—AGT—obesity	3.79e-06	6.15e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—APOE—obesity	3.71e-06	6.02e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CAV1—obesity	3.68e-06	5.97e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—APOA1—obesity	3.67e-06	5.95e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—obesity	3.51e-06	5.7e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PIK3CG—obesity	3.35e-06	5.44e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PPARG—obesity	3.23e-06	5.25e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—POMC—obesity	3.19e-06	5.17e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—INS—obesity	3.17e-06	5.15e-05	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—AKT1—obesity	3.15e-06	5.12e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PIK3CD—obesity	2.94e-06	4.78e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NOS3—obesity	2.78e-06	4.51e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PIK3R1—obesity	2.78e-06	4.51e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PIK3CB—obesity	2.57e-06	4.17e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PTGS2—obesity	2.54e-06	4.13e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PIK3CA—obesity	1.56e-06	2.54e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—AKT1—obesity	1.28e-06	2.07e-05	CbGpPWpGaD
